Immune System Changes May Drive Aggressiveness of Recurrent Tumors

The traditional view of recurrent tumors is that they are resistant to therapy because they've acquired additional genetic mutations that make them more aggressive and impervious to drugs. Now, however, researchers at the Perelman School of Medicine at the University of Pennsylvania show in an animal model that the enhanced aggressiveness of recurrent tumors may be due to changes in the body's ...

Read more:

Immune System Changes May Drive Aggressiveness of Recurrent Tumors

Related Posts

Comments are closed.